Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Swiss firm Clariant AG acquires IFF's cosmetic ingredients division for $810 million

EditorPollock Mondal
Published 10/30/2023, 03:31 AM
Updated 10/30/2023, 03:31 AM
© Reuters.

In a significant business move, Swiss firm Clariant AG (SIX:CLN) is set to acquire a cosmetic ingredients division from International Flavors & Fragrances Inc. (IFF) for $810 million. The division includes prominent brands such as Lucas Meyers Cosmetics and IBR. The deal, expected to close in the first quarter of 2024, has been devised to aid IFF in reducing its debt and strengthening its capital structure.

The announcement was made by IFF's CEO, Frank Clyburn. The division that Clariant will acquire operates six global sites dedicated to research and development as well as production. Last year, this business unit generated roughly $100 million in revenue.

Following the completion of the acquisition, IFF plans to focus on its core businesses as part of a strategy to enhance growth and returns.

InvestingPro Insights

In the light of this significant business move, it's crucial to keep an eye on the financial metrics of both companies. According to InvestingPro's real-time data, Clariant AG (CLN) has a Price/Earnings ratio of 31.0 and a Price/Book ratio of 0.99 as of Q4 2023. It also has a revenue of 95.07M USD, showing a significant potential for growth.

Two key InvestingPro Tips for CLN include the fact that the company has a high shareholder yield and is expected to see net income growth this year. This implies that the acquisition could further boost its financial performance. For more tips, visit InvestingPro, which provides 10 more insights about CLN.

On the other hand, International Flavors & Fragrances Inc. (IFF) has a market cap of 17.32B USD, with a negative P/E ratio of -7.88 as of Q2 2023. Its revenue stands at 11.86B USD. Two noteworthy InvestingPro Tips for IFF are that it has raised its dividend for 20 consecutive years and is expected to see growth in net income this year. This suggests that the sale of its cosmetic ingredients division could help improve its financial health. An additional 9 tips about IFF are available at InvestingPro.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Both companies' financial metrics and tips highlight the potential benefits of this acquisition for their respective financial futures.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.